Buprenorphine D4

N° de SZ CAT:	SZ-B095D02
Número CAS	NA
Mol.F.	C29H37D4NO4
Peso Molecular	471.7
Status de Fatura

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Nome Químico: (4R,4aS,6R,7R,7aR,12bS)-3-((cyclopropyl-2,2-d2)methyl-d2)-6-((S)-2-hydroxy-3,3-dimethylbutan-2-yl)-7-methoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: OC1=C2C3=C(C=C1)C[C@](N(C([2H])([2H])C4C([2H])([2H])C4)CC5)([H])[C@@]6(C[C@@]7([C@](C)(O)C(C)(C)C)[H])[C@]35[C@](O2)([H])[C@@]7(OC)CC6

Buprenorphine D4 is chemically (4R,4aS,6R,7R,7aR,12bS)-3-((cyclopropyl-2,2-d2)methyl-d2)-6-((S)-2-hydroxy-3,3-dimethylbutan-2-yl)-7-methoxy-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol. Buprenorphine D4 is supplied with detailed characterization data compliant with regulatory guideline. Buprenorphine D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Buprenorphine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Buprenorphine D4

Contacts

Our Locations